Laboratories that use revised carbapenem breakpoints detect significantly more carbapenem-resistant Enterobacteriaceae than laboratories that use historical ones.
Among patients aged 65 years or older who are hospitalized with community-acquired pneumonia, azithromycin lowers the risk of 90-day mortality in exchange for slightly increased odds of myocardial infarction compared to other antibiotic regimens.
A death from an antibiotic-resistant infection occurs about every 15 minutes in the United States. The CDC’s 2019 threat report dives into national infection estimates and actions we can take to combat this threat.
A recent CDC report finds those between 15 and 44 years of age are significantly more likely to have never been tested for HIV.
The Joint Commission considers hand hygiene the most important intervention for preventing healthcare-associated infections, which are responsible for 75,000 deaths annually.
Clinicians must identify when additional pounds cross the line of diminishing return.
According to recent data from the Centers for Disease Control and Prevention, millions of Americans aged 13-17 are under-vaccinated against serious infectious diseases.
Although a once-daily pill to prevent HIV exists, US populations at highest risk have the lowest rates of usage.
The high recurrence rates of Clostridioides difficile infection highlight the need for novel agents with unique mechanisms of action for treating the infection.
Pharmacists have the opportunity to take a lead role in providing education on the importance of vaccines in protecting people from preventable illnesses, according to a session which took place at the American Society of Health-System Pharmacists (ASHP) 54th Midyear Clinical Meeting & Exhibition.
Measles in Ontario, more endoscope-related infections, a study of postnatal Zika infections, research and development on a river blindness vaccine, and using CRISPR to tackle Zika are the articles that make up this week’s Top 5.
These pathogens can cause unique challenges for clinicians.
Biofilms are an emerging clinical problem despite the fact that most clinicians don’t even think of biofilms when managing infections.
Experts provide community physicians treating HIV with practical advice for screening, diagnosing, and managing patients with HIV.
Study ranks antibiotic classes by risk for rare, life-threatening cutaneous reactions of Stevens-Johnson syndrome and toxic epidermal necrolysis.
Experts provide community physicians treating HIV with practical advice for screening, diagnosing, and managing patients with HIV.
These tests have the potential to transform patient care and antimicrobial stewardship, but they have not gained widespread acceptance, partly because of uncertainty over how to use them clinically.
People who inject drugs who are infected with hepatitis C virus can achieve sustained viral response, despite imperfect adherence, according to the results of a new trial.
Saliva tests for detecting HCV infection may not be the best option for determining infection status.
In May 2017, a case of hepatitis A was detected in a Salt Lake County hospital. Over the next 20 months, Utah health officials worked to address what ended up being the largest hepatitis A outbreak in the state’s history.
Despite the initial abandonment of bacteriophages in most areas of the world, the era of antibiotic resistance has led to a resurgence of phage therapy in clinical practice.
Evolving research has led the infectious diseases community to redefine its definition of cure.
This case report is the fourth documented case of Lyme-induced syndrome of inappro­priate secretion of antidiuretic hormone (SIADH).
Here is a review of using this therapy in this patient population.
With AMR being a global priority, biosecurity-type policy around resistance may be part of the solution.
By stopping unnecessary antibiotics before they start, clinicians can avoid unnecessary harm to the patient and the population.
In this narrative review of studies evaluating antiretroviral stewardship programs (ARVSPs), we propose core elements for ARVSPs that are based on published evidence, clinical experience, and adapted from antimicrobial stewardship programs.